Almost 50% of COVID medicines produced in Kazakhstan – Tsoi
At a meeting of the Government of the Republic of Kazakhstan, Minister of Health of the Republic of Kazakhstan Alexey Tsoi noted that 48 percent of drugs for Covid-19 are produced domestically, Kazpravda.kz reports.
"The share of purchases through the Single distributor on the country's pharmaceutical market is 42.4 percent in monetary terms. The share of domestic producers in the pharmaceutical market of Kazakhstan is 17 percent in monetary terms; the domestic producers cover 39 percent of the market in kind. In recent years, an increase in exports has been noted in domestic producers by 4.3 times, where 57.2 percent are exported to Russia, 32 percent - to Kyrgyzstan," the speaker said.
The minister added that one of the strategic tasks of the state is to support domestic developments and development of a competitive pharmaceutical industry.
"The main stimulus for the growth of local production of pharmaceuticals is the program for concluding long-term contracts with domestic manufacturers for a period of up to 10 years. During the period from 2009 to 2020, 88 long-term contracts were concluded for the supply of 5,042 items of drugs and medical devices as part of the purchase by the Single distributor," added Tsoi.
According to him, over 10 years, the products of domestic producers have been purchased for more than 312.4 billion tenge. More than 30% of the volume purchased by the Single distributor is made by the domestic producers. 48% of COVID-19 medicines are produced domestically.